Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Pozycja w akcjach #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Cena akcji
$88.89
Kapitalizacja rynkowa
$114.13B
Zmiana (1 dzień)
-0.93%
Zmiana (1 rok)
-2.08%
Kraj
IE
Handel Medtronic plc (2M6)

Kategoria

Przychody dla Medtronic plc (2M6)
Przychody w Jan 2026 TTM: $35.49B
Według najnowszych raportów finansowych Medtronic plc, obecny przychód firmy (TTM) wynosi $35.49B. W roku 2024 firma osiągnęła przychód w wysokości $32.36B wzrost w porównaniu do przychodu z roku 2023, który wynosił $31.23B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Medtronic plc od 2000 do 2026
Przychody na koniec każdego roku
Rok Przychody Zmień
2026 (TTM) $35.49B 5.83%
2025 $33.54B 3.62%
2024 $32.36B 3.64%
2023 $31.23B -1.45%
2022 $31.69B 5.21%
2021 $30.12B 4.16%
2020 $28.91B -5.38%
2019 $30.56B 2.02%
2018 $29.95B 0.82%
2017 $29.71B 3.04%
2016 $28.83B 42.31%
2015 $20.26B 19.15%
2014 $17.01B 2.50%
2013 $16.59B 2.51%
2012 $16.18B 1.58%
2011 $15.93B 0.73%
2010 $15.82B 8.34%
2009 $14.60B 8.02%
2008 $13.52B 9.89%
2007 $12.30B 8.92%
2006 $11.29B 12.31%
2005 $10.05B 10.65%
2004 $9.09B 18.55%
2003 $7.67B 19.57%
2002 $6.41B 15.47%
2001 $5.55B 10.71%
2000 $5.01B 0.00%
Przychody podobnych firm lub konkurentów
Firma Przychody Różnica w przychodach Kraj
$44.33B 24.90%
US
$25.12B -29.23%
US
$35.48B -0.02%
IE
$20.08B -43.44%
US
$25.70B -27.60%
DE